Application of a Deuterium Replacement Strategy to Modulate the Pharmacokinetics of 7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-3-(4-methoxy-2-methylphenyl)-2,6-dimethylpyrazolo[5,1-b]oxazole, a Novel CRF1 Antagonist
2014 ◽
Vol 42
(5)
◽
pp. 954-962
◽
Keyword(s):
2010 ◽
Vol 102-104
◽
pp. 846-850